Treatment of Purulent Skin Infection by Central Venous Catheter

Rationale for Vancomycin as First-Line Therapy

The American College of Physicians recommends vancomycin as the preferred treatment for purulent skin infection associated with a central venous catheter due to its efficacy against Staphylococcus species 1
Staphylococci account for 60-70% of catheter-related bloodstream infections, making coverage for these organisms essential 2
For S. aureus infections, the catheter should be removed and systemic antibiotic therapy with vancomycin implemented 3, 4

Obtain blood cultures from both the catheter and peripheral vein before starting antibiotics, as recommended by the Infectious Diseases Society of America 2, 6
Assess for signs of severe infection, tunnel infection, or port pocket abscess 6
Remove the catheter if severe sepsis, tunnel infection, port abscess, S. aureus infection, or fungal infection is present, as suggested by the Annals of Oncology 3, 6, 7

Start with vancomycin as empiric therapy, as recommended by the Praxis Medical Insights 1
Consider adding gram-negative coverage if the patient is critically ill or has risk factors for gram-negative infection 1
Adjust therapy based on culture results and clinical response 6

For uncomplicated infections, treat for 10-14 days after resolution of signs of infection, as recommended by the Annals of Oncology 4, 7
For complicated infections, treat for 4-6 weeks 4, 7

For catheter salvage attempts, use antibiotic lock therapy in addition to systemic therapy, as suggested by the Annals of Oncology and Praxis Medical Insights 1, 4

Do not delay obtaining cultures before starting antibiotics, as this may reduce diagnostic yield, according to the Annals of Oncology and Praxis Medical Insights 2, 6
Do not attempt catheter salvage in S. aureus infections, as this is associated with treatment failure and complications, as reported by the Annals of Oncology 3, 4
Avoid underdosing vancomycin, as this may contribute to treatment failure and development of resistance, as warned by the Praxis Medical Insights 1
Do not continue empiric therapy without adjusting based on culture results, as this may lead to unnecessary broad-spectrum antibiotic use, according to the Praxis Medical Insights 6